Validity of the rapid strip assay test for detecting HBsAg in patients admitted to hospital in Uganda

Journal of Medical Virology

Volumn 82, Issue 8, 2010, Pages 1334-1340

  Seremba, E ^a,b   Ocama, P ^a   Opio, C K ^a   Kagimu, M ^a   Yuan, H J ^a,b,c   Attar, N ^a,c   Thomas, D L ^b   Lee, W M ^a,c  

^a MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Enzyme immunoassay; HBsAg; Nucleic acid testing; Rapid strip assay

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NUCLEIC ACID; VIRUS DNA; HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME IMMUNOASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; RAPID STRIP ASSAY; SEROLOGY; UGANDA; VALIDATION PROCESS; BLOOD; HEPATITIS B; HEPATITIS B VIRUS; HOSPITAL; IMMUNOASSAY; ISOLATION AND PURIFICATION; MIDDLE AGED; PROCEDURES; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DNA, VIRAL; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HIV ANTIBODIES; HOSPITALS; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; UGANDA; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 77956569649     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21813     Document Type: Article

References (23)

1. Abebe A, Nokes DJ, Dejene A, Enquselassie F, Messele T, Cutts FT. 2003. Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: Transmission patterns and vaccine control. Epidemiol Infect 131:757-770.
2. Alberti A, Clumeck N, Collins S, Gerlich W, Lundgren J, Palu G, Reiss P, Thiebaut R, Weiland O, Yazdanpanah Y, Zeuzem S. 2005. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol 42:615-624.
3. Allain JP, Belkhiri D, Vermeulen M, Crookes R, Cable R, Amiri A, Reddy R, Bird A, Candotti D. 2009. Characterization of occult hepatitis B virus strains in South African blood donors. Hepatology 49:1868-1876.
4. Aye TT, Bartholomeusz A, Shaw T, Bowden S, Breschkin A, McMillan J, Angus P, Locarnini S. 1997. Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. J Hepatol 26:1148-1153. (Pubitemid 27242606)
5. Baumert TF, Barth H, Blum HE. 2005. Genetic variants of hepatitis B virus and their clinical relevance. Minerva Gastroenterol Dietol 51:95-108.
6. Braka F, Nanyunja M, Makumbi I, Mbabazi W, Kasasa S, Lewis RF. 2006. Hepatitis B infection among health workers in Uganda: Evidence of the need for health worker protection. Vaccine 24:6930-6937. (Pubitemid 46107192)
7. Burnett RJ, Francois G, Kew MC, Leroux-Roels G, Meheus A, Hoosen AA, Mphahlele MJ. 2005. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: A call for further investigation. Liver Int 25:201-213.
8. Bwogi J, Braka F, Makumbi I, Mishra V, Bakamutumaho B, Nanyunja M, Opio A, Downing R, Biryahwaho B, Lewis RF. 2009. Hepatitis B infection is highly endemic in Uganda: Findings from a national serosurvey. Afr Health Sci 9:98-108.
9. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. 1999. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 341:22-26. (Pubitemid 29293716)
10. Dufour DR. 2006. Hepatitis B surface antigen (HBsAg) assays - Are they good enough for their current uses? Clin Chem 52:1457-1459.
11. Emmanuel JC, Bassett MT, Smith HJ. 1988. Risk of hepatitis B infection among medical and paramedical workers in a general hospital in Zimbabwe. J Clin Pathol 41:334-336.
12. Lee WM. 1997. Hepatitis B virus infection. N Engl J Med 337:1733-1745.
13. Lok AS, McMahon BJ. 2001. Chronic hepatitis B. Hepatology 34:1225-1241.
14. Ly TD, Servant-Delmas A, Bagot S, Gonzalo S, Ferey MP, Ebel A, Dussaix E, Laperche S, Roque-Afonso AM. 2006. Sensitivities of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms. J Clin Microbiol 44: 2321-2326.
15. Ocama P, Opio CK, Lee WM. 2005. Hepatitis B virus infection: Current status. Am J Med 118:1413.
16. Ono-Nita SK, Kato N, Shiratori Y, Masaki T, Lan KH, Carrilho FJ, Omata M. 1999. YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection. Hepatology 29:939-945. (Pubitemid 29109613)
17. Sato K, Ichiyama S, Iinuma Y, Nada T, Shimokata K, Nakashima N. 1996. Evaluation of immunochromatographic assay systems for rapid detection of hepatitis B surface antigen and antibody, Dainascreen HBsAg and Dainascreen Ausab. J Clin Microbiol 34:1420-1422.
18. Selabe SG, Lukhwareni A, Song E, Leeuw YG, Burnett RJ, Mphahlele MJ. 2007. Mutations associated with lamivudine-resistance in therapy-naive hepatitis B virus (HBV) infected patients with and without HIV co-infection: Implications for antiretroviral therapy in HBV and HIV co-infected South African patients. J Med Virol 79: 1650-1654.
19. Tenney DJ, Levine SM, Rose RE, Walsh AW, Weinheimer SP, Discotto L, Plym M, Pokornowski K, Yu CF, Angus P, Ayres A, Bartholomeusz A, Sievert W, Thompson G, Warner N, Locarnini S, Colonno RJ. 2004. Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine. Antimicrob Agents Chemother 48:3498-3507.
20. Tswana S, Chetsanga C, Nystrom L, Moyo S, Nzara M, Chieza L. 1996. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe. S Afr Med J 86:72-75. (Pubitemid 26058909)
21. Uneke CJ, Ogbu O, Inyama PU, Anyanwu GI, Njoku MO, Idoko JH. 2005. Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. Mem Inst Oswaldo Cruz 100:13-16. (Pubitemid 40385725)
22. van Helden J, Denoyel G, Karwowska S, Reamer R, Schmalz J, Wright T, Preisel-Simmons B. 2004. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System. Clin Lab 50:63-73. (Pubitemid 38268396)
23. Yeh CT, Chien RN, Chu CM, Liaw YF. 2000. Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy. Hepatology 31:1318-1326.